South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022
South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthSouth Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022
View Premium plansBrowse free archive reportsSouth Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.